Loading…
Takeda says Ka Pow IBD

Takeda says Ka Pow IBD

Takeda worked with the Crohn’s and Colitis Foundation of America and Marvel Custom Solutions to create its first-ever pharma company-sponsored superhero to shine a light on the many sufferers of IBD who hide their disease. The disease awareness campaign includes the graphic illustration series with IBD-suffering hero Samarium, as well as digital paid ads and social media shares.

Stephanie Brown, VP of Takeda’s specialty business unit in the U.S., said in a statement that “our hope is that patients will feel inspired to have the raw and real conversations they need to have with healthcare professionals, family, and friends, to increase awareness, understanding, and to strive for the best care for their IBD.”

The first-in-the-series online comic, out now, will be made into actual comic books and distributed at some events, including several Comic-Con festivals that Takeda will attend, a Takeda spokeswoman told FiercePharmaMarketing. She said more stories are planned for the graphic illustration series, including global editions. And for every view of the online graphic at IBDUnmasked.com, Takeda will donate $1 to CCFA, up to $25,000.

Takeda markets IBD biologic Entyvio, although that brand is not mentioned in this disease awareness campaign. Entyvio, which did launch a branded ad campaign earlier this year, faces competition in a crowded IBD space where it’s up against established Crohn’s and ulcerative colitis brands such as AbbVie’s Humira, Amgen’s Enbrel, and Johnson & Johnson’s Remicade and follow-up Simponi.

Takeda marketers were introduced to Marvel through a mutual agency partner. The ideas for the graphic were then generated in an all-day brainstorming session that included Takeda and CCFA representatives, along with patients who have Crohn’s disease or ulcerative colitis.

The initial response has been “incredibly positive” from patients, the spokeswoman said, pointing out that “even when you work in a heavily regulated environment, you can still be creative and create something interesting and compelling enough for people to want to share it.”

Takeda’s press release

 
Environment impact on health

Environment impact on health

Toronto researchers to investigate environment’s impact on healthFour researchers at the University of Toronto and its affiliated research centres are receiving $2-million each to investigate how environmental factors can impact health. The funding from the Canadian Institutes of Health Research was announced today by federal health minister, the Honourable Jane Philpott.

“This research funding will enable researchers to use these new technologies to better understand the complex interactions that cause chronic disease, and ultimately help us to identify better ways to prevent and treat chronic disease conditions,” said Dr. Philip Sherman, Scientific Director of the CIHR Institute of Nutrition, Metabolism and Diabetes.

Those funds will help Professor Jennifer Gommerman investigate autoimmune disease in South Asian Canadians. As she explains, the project will provide insight on how a change in one’s environmental setting can impact health.

“Immigration often transplants individuals and families into radically different environments in terms of climate, prevailing diet, exposure to microbial pathogens, exposure to pollutants, and changes in lifestyle dictated by economic necessity; yet, we know little about the impact of global migration on health and disease,” says Gommerman, an immunology professor.

This work will help patients like Rasheed Clarke who suffers from ulcerative colitis.

“My parents are both from India and I still have family who live there. I was born in Canada and developed ulcerative colitis. There was never a case of inflammatory bowel disease in my family. So I wonder, what is it about the environment here that triggered UC in me? I have the feeling that I wouldn’t have developed colitis if I was born and raised in India, but I don’t know that for sure, which is why this research is so important,” said Clarke.

This research is also being supported by Crohn’s and Colitis Canada.

“Canada has among the highest rates of inflammatory bowel disease (IBD) in the world. Increasingly we are seeing families new to Canada developing IBD for the first time” says Mina Mawani, President and CEO, Crohn’s and Colitis Canada. “This research will shed new light as to how our Canadian environment and diet contribute to the development of Crohn’s disease and ulcerative colitis, and brings us closer to new ways to prevent and treat these diseases affecting nearly 250,000 Canadians.”

The other projects supported by today’s announcement are:

Immunology Professor Alberto Martin will investigate the impact gut microbiome and the environment can contribute to the development of colorectal cancer, which is the second leading cause of cancer-related deaths in Canada.

Read more: Environment impact on health

     

    Invest 16 Million Over Five Years Government of Canada

    Invest 16 Million Over Five Years Government of Canada For Immediate Release

    Government of Canada combats chronic health conditions
    Researchers to study link between environmental and genetic factors and the development of asthma, diabetes, and other chronic conditions
    May 2, 2016 – Ottawa, Ontario – Canadian Institutes of Health Research

    Newswise — The Honourable Jane Philpott, Minister of Health, today announced an investment of $16M over five years to support new research that will help find new ways to prevent or treat chronic conditions affecting millions of Canadians.

    It is commonly understood that both environmental and genetic factors play a role in the development of chronic conditions such as asthma, diabetes, and inflammatory bowel disease. A child with asthma, for example, can inherit a genetic predisposition to the condition from their parents and episodes can be triggered from breathing in irritants like pollen and cigarette smoke. But how exactly genes interact with the environment to contribute to these health conditions is not well understood.

    To close this knowledge gap, the Government of Canada, through the Canadian Institutes of Health Research, is funding eight new research teams. Funding partners for select projects include Genome BC and Crohn’s and Colitis Canada.

    These teams will advance our understanding of the complex interaction between our genes and the environment in which we live and guide the development of new approaches to prevent, treat or better manage chronic conditions. Their work promises to improve the lives of Canadians and reduce the burden on our health care system.

    “Millions of Canadians, such as our children, seniors, family and friends, live with chronic conditions, affecting their quality of life and placing a great deal of stress on their loved ones. We are pleased to support these outstanding research teams that will produce important new knowledge and help make life better for Canadians living with chronic disease and their families. I wish the teams every success as they carry out their research projects.”

    The Honourable Jane Philpott
    Minister of Health “Most chronic diseases, such as diabetes, inflammatory bowel disease and obesity, involve multiple genes in complex interactions with environmental influences.

    New technologies have emerged that provide researchers with a greater understanding of the genome, the epigenome, the microbiome, and the metabolome. This research funding will enable researchers to use these new technologies to better understand the complex interactions that cause chronic disease, and ultimately help us to identify better ways to prevent and treat chronic disease conditions.”

    Dr. Philip Sherman Scientific Director, CIHR Institute of Nutrition, Metabolism and Diabetes
    “Predicting and preventing chronic disease is the kind of real world challenge that ‘omics’ technologies can help tackle. By mapping the DNA of a patient’s complete environment, new insights and approaches can be created to reduce the burden of chronic disease, We are proud to be supporting world class researchers as they push boundaries towards a future that offers solutions with unparalleled efficiency and precision.”

    Dr. Catalina Lopez-Correa
    Vice President, Sectors and Chief Scientific Officer, Genome British Columbia
    “Canada has among the highest rates of inflammatory bowel disease (IBD) in the world. Increasingly we are seeing families new to Canada developing IBD for the first time – often within the first generation. This research will shed new light as to how our Canadian environment and diet contribute to the development of Crohn’s disease and ulcerative colitis, and brings us closer to new ways to prevent and treat these diseases affecting nearly 250,000 Canadians.”

    Mina Mawani
    President and CEO, Crohn’s and Colitis Canada
    Related Products
    • Podcast with Dr. Philip Sherman
    • Backgrounder
    Associated Links
    • CIHR Signature Initiative on Environments and Health
    • The Canadian Healthy Infant Longitudinal Development (CHILD) Study (video)
    Contacts
    Andrew MacKendrick
    Office of the Honourable Jane Philpott
    Minister of Health
    613-957-0200
    David Coulombe
    Media Relations
    Canadian Institutes of Health Research
    613-941-4563
    [email protected]

    The Canadian Institutes of Health Research (CIHR) is the Government of Canada’s health research investment agency. CIHR’s mission is to create new scientific knowledge and to enable its translation into improved health, more effective health services and products, and a strengthened health care system for Canadians. Composed of 13 Institutes, CIHR provides leadership and support to more than 13,000 health researchers and trainees across Canada.